Retinoblastoma Clinical Trials Retinoblastoma RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Episcleral Topotecan for Treatment of Group D Retinoblastoma
Condition:   Retinoblastoma Intervention:   Drug: Episcleral Topotecan Sponsor:   Targeted Therapy Technologies, LLC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 7, 2019 Category: Research Source Type: clinical trials